R. Thomson, et al. (2022). Home-based Intermittent Inhaled High-Dose Nitric Oxide (NO) in Nontuberculous Mycobacterial Pulmonary Disease Using a Novel NO Generator and Delivery System is Safe and Well-Tolerated. American Thoracic Society Conference 2022 (ATS 2022). May 13-18, 2022.

A. Goldbart, et al. (2022) Long-term effects of inhaled nitric oxide in infants with bronchiolitis – a multi center study. Pediatric Academic Societies Meeting 2022 (PAS 2022). April 21-25, 2022.

T. Wolak, et al. (2022) Treatment of COVID-19 With Inhaled Nitric Oxide Using A Novel Nitric Oxide Generator. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022. April 23-26, 2022.

Goldbart A et al. (2021) Non-tuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide. BMJ Case Rep. 2021 Oct 28

Asher T. et al (2021) Efficacy and Safety of Inhaled Nitric Oxide for the Treatment of Acute Bronchiolitis: An Evaluation of Three Trials. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Wolak T. et al (2021) Inhaled Nitric Oxide for the Treatment of COVID-19 and Other Viral Pneumonias in Adults. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Confino H. et al (2020) Nitric Oxide Tumor Ablation Stimulates an Anti-Tumor Immune Response in Mice. American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy, October 19-20, 2020.

Goldshtein M. et al (2020). Nitric Oxide is a Powerful Anti-Coronavirus Inhaled Agent that Acts Within Hours. CHEST Annual Meeting, October 18-21, 2020.

Goldbart A. et al (2020). Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently via Inhalation to Subjects with Bronchiolitis – a Multi-Center Double Blind Study. CHEST Annual Meeting, October 18-21, 2020.

Confino H. et al (2020). Nitric Oxide Lung Cancer Active Vaccination. 2020 North American Conference on Lung Cancer, October 16th.

• 1
• 2
• 3
• 4
• Next »